
Sign up to save your podcasts
Or


Spinogenix Founder and CEO Stella Sarraf sits with ForbesWomen Editor Maggie McGrath at the Nasdaq MarketSite to discuss her company's novel approach to treating neurodegenerative disease at the synaptic level.
See Privacy Policy at https://art19.com/privacy and California Privacy Notice at https://art19.com/privacy#do-not-sell-my-info.
By Forbes Media LLC4.8
66 ratings
Spinogenix Founder and CEO Stella Sarraf sits with ForbesWomen Editor Maggie McGrath at the Nasdaq MarketSite to discuss her company's novel approach to treating neurodegenerative disease at the synaptic level.
See Privacy Policy at https://art19.com/privacy and California Privacy Notice at https://art19.com/privacy#do-not-sell-my-info.

11,152 Listeners

4,185 Listeners

1,720 Listeners

4,356 Listeners

408 Listeners

432 Listeners

1,640 Listeners

672 Listeners

1,450 Listeners

1,041 Listeners

182 Listeners

510 Listeners

1,307 Listeners

6,076 Listeners

755 Listeners

13 Listeners

5 Listeners